Use of a computer-based provider order entry (CPOE) intervention to optimize laboratory testing in patients with suspected heparin-induced thrombocytopenia.

INTRODUCTION Heparin-induced thrombocytopenia (HIT) is a rare but frequently considered diagnosis in hospitalized patients. Despite the availability of clinical prediction tools, HIT is often over-diagnosed and patients can be subjected to unnecessary and expensive testing. METHODS A decision-support tool requiring providers to calculate the 4Ts (HIT risk) score prior to ordering laboratory-based tests for anti-PF4/heparin antibody enzyme-linked immunosorbent assay (ELISA) testing was implemented at our institution in January 2014. Charts of adult patients who underwent ELISA or serotonin release assay (SRA) testing during the 8-month time periods prior to and following this intervention were reviewed and 4Ts scores at the time of ELISA or SRA testing were calculated. RESULTS A total of 443 ELISA and SRA tests were sent for 411 patients during the time periods studied. We observed a significant decrease from 43 tests/month before to 22 tests/month (p < 0.001) after the intervention. A total of 337 charts were reviewed. We observed a trend toward decrease in the proportion of tested patients with low 4Ts scores (66% vs 56%, p = 0.069), as well as an increase in the average 4Ts score of tested patients (3.0 vs 3.4, p = 0.010) following our intervention. DISCUSSION Over-testing and treatment for HIT are frequent and potentially harmful occurrences in hospitalized patients. Our study demonstrates that a clinical decision support tool embedded within the electronic ordering process can decrease unnecessary testing for HIT.

[1]  L. Kulik,et al.  Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes. , 2014, Annals of hepatology.

[2]  Insung Chung,et al.  Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample. , 2014, Journal of cardiothoracic and vascular anesthesia.

[3]  S. Goldhaber,et al.  Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism. , 2014, European heart journal.

[4]  A. Greinacher.  CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. , 2015, The New England journal of medicine.

[5]  P. Crilley,et al.  Evaluation of a Pretest Scoring System (4Ts) for the Diagnosis of Heparin-Induced Thrombocytopenia in a University Hospital Setting , 2012, Postgraduate medicine.

[6]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[7]  T. Ortel,et al.  Clinical practice. Heparin-induced thrombocytopenia. , 2006, New England Journal of Medicine.

[8]  D. Steinke,et al.  Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia , 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[9]  A. Girolami,et al.  Heparin-induced thrombocytopenia: a review. , 2006, Seminars in thrombosis and hemostasis.

[10]  A. Dans,et al.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[11]  C. Sigouin,et al.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings , 2006, Journal of thrombosis and haemostasis : JTH.

[12]  A. Dans,et al.  Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2011 .

[13]  T. Ortel,et al.  Heparin-induced thrombocytopenia. , 2006, Seminars in hematology.

[14]  M. Smythe,et al.  Implications of Heparin-Induced Thrombocytopenia Overdiagnosis , 2014, The Annals of pharmacotherapy.

[15]  T. Warkentin.  Heparin-induced thrombocytopenia in the ICU: a transatlantic perspective. , 2012, Chest.

[16]  K. McCrae,et al.  Over-testing for heparin induced thrombocytopenia in hospitalized patients , 2015, Journal of Thrombosis and Thrombolysis.

[17]  T. Warkentin.  Heparin-Induced Thrombocytopenia in Critically Ill Patients , 2015, Seminars in Thrombosis and Hemostasis.

[18]  P. Fontana,et al.  Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? , 2015, Platelets.